Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury
ACS Nano · 18.03.2025 · 19 (10) · 10529-10548
DOI: 10.1021/acsnano.5c01434 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 06.03.2025. Verfasst von Zhifei Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hef…. Hauptthemen laut MEDLINE: Pyroptosis, Reperfusion Injury, Microglia, Brain Ischemia. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Anhui Provincial Department of Education, National Natural Science Foundation of China, Anhui University Collaborative Innovation Project.
Abstract (Originalsprache)
Neuroinflammation is a critical factor in the progression of cerebral ischemia-reperfusion injury (CIRI). Pyroptosis, which is an inflammatory form of programmed cell death, greatly amplifies neuroinflammatory processes. It does so by promoting the release of various inflammatory contents that intensify the overall inflammatory response within the central nervous system. Therefore, targeting pyroptosis represents a promising therapeutic strategy for the treatment of CIRI. Excessive generation of reactive oxygen species (ROS) by overactivated microglia is considered to serve as the signal molecule that triggers NLRP3 inflammasome-mediated pyroptosis. However, current pyroptosis inhibitors that solely focus on eliminating existing ROS or inhibiting the NLRP3 inflammasome are not optimal. Here, by coating nanothylakoids (NTs) coengineered with fibrin-binding peptide and MG1 peptide onto dihydrotanshinone I (DT)-loaded nanocarriers, we have developed a cascade-type pyroptosis inhibitor (MDN-MC) that comprehensively regulates the ROS/NLRP3/pyroptosis axis. The incorporation of catalase on the surface of MDN-MC, along with the release of DT, facilitated cascade inhibition of pyroptosis by scavenging existing ROS and suppressing the expression of NLRP3. In the rat model of transient middle cerebral artery occlusion, enhanced behavioral recovery and facilitated neuronal repair were achieved through cascade targeting of inflammatory microglia at the lesion site and implementation of interventions to inhibit pyroptosis, thereby demonstrating promising therapeutic effects. Overall, this work emphasizes the importance of cascade-regulated pyroptosis in reducing neuroinflammation, offering an important mechanistic understanding and possible therapeutic approaches for CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230012, China.
- Institute of Pharmaceutics, Anhui Academy of Chinese Medicine, Hefei 230012, China.
- Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei, Anhui 230012, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui 230012, China.
- School of Pharmacy, Anhui Medical University, Hefei 230032, China.
ORCID-Profile: Zhifei Cheng, Qi Liu, Qi Wang
Förderung
- Anhui Provincial Department of Education
- National Natural Science Foundation of China
- Anhui University Collaborative Innovation Project
- Youth Project of Natural Science Foundation of Anhui Province
- Anhui University of Chinese Medicine Foundation
Zitieren
APA
Cheng, Z., Shao, W., Wei, C., Zhang, Y., Xiao, R., Zhang, S., Zhang, J., She, Y., Pan, C., Liu, Q., & Wang, Q. (2025). Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury. ACS Nano, 19(10), 10529-10548. https://doi.org/10.1021/acsnano.5c01434
Vancouver
Cheng Z, Shao W, Wei C, Zhang Y, Xiao R, Zhang S, et al. Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury. ACS Nano. 2025;19(10):10529-10548. doi:10.1021/acsnano.5c01434
BibTeX
@article{Cheng2025,
author = {Cheng, Zhifei and Shao, Wei and Wei, Chaoqi and Zhang, Yaru and Xiao, Ru and Zhang, Shuai and Zhang, Jingyi and She, Yunfei and Pan, Chenglin and Liu, Qi and Wang, Qi},
title = {Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {10},
pages = {10529--10548},
doi = {10.1021/acsnano.5c01434}
}
EUVIMED